Discovery of N-Hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-α converting enzyme (TACE)-Reference-Cited by-同舟云学术

Discovery of N-Hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-α converting enzyme (TACE)

Published:2003-06 Issue:12 Volume:13 Page:2035-2040
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Duan James J.-W.,Lu Zhonghui,Xue Chu-Biao,He Xiaohua,Seng Jennifer L.,Roderick John J.,Wasserman Zelda R.,Liu Rui-Qin,Covington Maryanne B.,Magolda Ronald L.,Newton Robert C.,Trzaskos James M.,Decicco Carl P.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Human tumor necrosis factor. Production, purification, and characterization.

2. Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

3. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

4. Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-α

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxamates;Privileged Structures in Drug Discovery;2018-03-09

2. Stereospecific Preparation of γ-Lactam Derivatives via Ring Expansion ofcisandtransβ-Lactam Derivatives: α-Substituent Effect of β-Lactam Derivatives;Bulletin of the Korean Chemical Society;2016-03-18

3. Divergent, stereoselective access to heterocyclic α,α-quaternary- and β2,3,3-amino acid derivatives from a N-Pmp-protected Orn-derived β-lactam;Organic & Biomolecular Chemistry;2015

4. Palladium-catalyzed asymmetric synthesis of 2-pyrrolidinones with a quaternary carbon stereocenter;Chemical Communications;2012

5. 2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors;Bioorganic & Medicinal Chemistry Letters;2011-05